Rationale and methods of the european study on cardiovascular risk prevention and management in daily practice (EURIKA)

Fernando Rodríguez-Artalejo, Eliseo Guallar, Claudio Borghi, Jean Dallongeville, Guy De Backer, Julian P. Halcox, Ramán Hernndez-Vecino, Francisco Javier Jiménez, Elvira L. Massá-Gonzlez, Joep Perk, Philippe Gabriel Steg, José R. Banegas

Research output: Contribution to journalArticle

Abstract

Background. The EURIKA study aims to assess the status of primary prevention of cardiovascular disease (CVD) across Europe. Specifically, it will determine the degree of control of cardiovascular risk factors in current clinical practice in relation to the European guidelines on cardiovascular prevention. It will also assess physicians' knowledge and attitudes about CVD prevention as well as the barriers impeding effective risk factor management in clinical practice. Methods/Design. Cross-sectional study conducted simultaneously in 12 countries across Europe. The study has two components: firstly at the physician level, assessing eight hundred and nine primary care and specialist physicians with a daily practice in CVD prevention. A physician specific questionnaire captures information regarding physician demographics, practice settings, cardiovascular prevention beliefs and management. Secondly at the patient level, including 7641 patients aged 50 years or older, free of clinical CVD and with at least one classical risk factor, enrolled by the participating physicians. A patient-specific questionnaire captures information from clinical records and patient interview regarding sociodemographic data, CVD risk factors, and current medications. Finally, each patient provides a fasting blood sample, which is sent to a central laboratory for measuring serum lipids, apolipoproteins, hemoglobin-A1c, and inflammatory biomarkers. Discussion. Primary prevention of CVD is an extremely important clinical issue, with preventable circulatory diseases remaining the leading cause of major disease burden. The EURIKA study will provide key information to assess effectiveness of and attitudes toward primary prevention of CVD in Europe. A transnational study creates opportunities for benchmarking good clinical practice across countries and improving outcomes.

Original languageEnglish (US)
Article number382
JournalBMC Public Health
Volume10
DOIs
StatePublished - 2010

Fingerprint

Risk Management
Cardiovascular Diseases
Physicians
Primary Prevention
Benchmarking
Apolipoproteins
Primary Care Physicians
Fasting
Hemoglobins
Cross-Sectional Studies
Biomarkers
Demography
Guidelines
Interviews
Lipids
Serum

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Rodríguez-Artalejo, F., Guallar, E., Borghi, C., Dallongeville, J., De Backer, G., Halcox, J. P., ... Banegas, J. R. (2010). Rationale and methods of the european study on cardiovascular risk prevention and management in daily practice (EURIKA). BMC Public Health, 10, [382]. https://doi.org/10.1186/1471-2458-10-382

Rationale and methods of the european study on cardiovascular risk prevention and management in daily practice (EURIKA). / Rodríguez-Artalejo, Fernando; Guallar, Eliseo; Borghi, Claudio; Dallongeville, Jean; De Backer, Guy; Halcox, Julian P.; Hernndez-Vecino, Ramán; Jiménez, Francisco Javier; Massá-Gonzlez, Elvira L.; Perk, Joep; Steg, Philippe Gabriel; Banegas, José R.

In: BMC Public Health, Vol. 10, 382, 2010.

Research output: Contribution to journalArticle

Rodríguez-Artalejo, F, Guallar, E, Borghi, C, Dallongeville, J, De Backer, G, Halcox, JP, Hernndez-Vecino, R, Jiménez, FJ, Massá-Gonzlez, EL, Perk, J, Steg, PG & Banegas, JR 2010, 'Rationale and methods of the european study on cardiovascular risk prevention and management in daily practice (EURIKA)', BMC Public Health, vol. 10, 382. https://doi.org/10.1186/1471-2458-10-382
Rodríguez-Artalejo, Fernando ; Guallar, Eliseo ; Borghi, Claudio ; Dallongeville, Jean ; De Backer, Guy ; Halcox, Julian P. ; Hernndez-Vecino, Ramán ; Jiménez, Francisco Javier ; Massá-Gonzlez, Elvira L. ; Perk, Joep ; Steg, Philippe Gabriel ; Banegas, José R. / Rationale and methods of the european study on cardiovascular risk prevention and management in daily practice (EURIKA). In: BMC Public Health. 2010 ; Vol. 10.
@article{aceb7d31e62945e5b94629f621983a04,
title = "Rationale and methods of the european study on cardiovascular risk prevention and management in daily practice (EURIKA)",
abstract = "Background. The EURIKA study aims to assess the status of primary prevention of cardiovascular disease (CVD) across Europe. Specifically, it will determine the degree of control of cardiovascular risk factors in current clinical practice in relation to the European guidelines on cardiovascular prevention. It will also assess physicians' knowledge and attitudes about CVD prevention as well as the barriers impeding effective risk factor management in clinical practice. Methods/Design. Cross-sectional study conducted simultaneously in 12 countries across Europe. The study has two components: firstly at the physician level, assessing eight hundred and nine primary care and specialist physicians with a daily practice in CVD prevention. A physician specific questionnaire captures information regarding physician demographics, practice settings, cardiovascular prevention beliefs and management. Secondly at the patient level, including 7641 patients aged 50 years or older, free of clinical CVD and with at least one classical risk factor, enrolled by the participating physicians. A patient-specific questionnaire captures information from clinical records and patient interview regarding sociodemographic data, CVD risk factors, and current medications. Finally, each patient provides a fasting blood sample, which is sent to a central laboratory for measuring serum lipids, apolipoproteins, hemoglobin-A1c, and inflammatory biomarkers. Discussion. Primary prevention of CVD is an extremely important clinical issue, with preventable circulatory diseases remaining the leading cause of major disease burden. The EURIKA study will provide key information to assess effectiveness of and attitudes toward primary prevention of CVD in Europe. A transnational study creates opportunities for benchmarking good clinical practice across countries and improving outcomes.",
author = "Fernando Rodr{\'i}guez-Artalejo and Eliseo Guallar and Claudio Borghi and Jean Dallongeville and {De Backer}, Guy and Halcox, {Julian P.} and Ram{\'a}n Hernndez-Vecino and Jim{\'e}nez, {Francisco Javier} and Mass{\'a}-Gonzlez, {Elvira L.} and Joep Perk and Steg, {Philippe Gabriel} and Banegas, {Jos{\'e} R.}",
year = "2010",
doi = "10.1186/1471-2458-10-382",
language = "English (US)",
volume = "10",
journal = "BMC Public Health",
issn = "1471-2458",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Rationale and methods of the european study on cardiovascular risk prevention and management in daily practice (EURIKA)

AU - Rodríguez-Artalejo, Fernando

AU - Guallar, Eliseo

AU - Borghi, Claudio

AU - Dallongeville, Jean

AU - De Backer, Guy

AU - Halcox, Julian P.

AU - Hernndez-Vecino, Ramán

AU - Jiménez, Francisco Javier

AU - Massá-Gonzlez, Elvira L.

AU - Perk, Joep

AU - Steg, Philippe Gabriel

AU - Banegas, José R.

PY - 2010

Y1 - 2010

N2 - Background. The EURIKA study aims to assess the status of primary prevention of cardiovascular disease (CVD) across Europe. Specifically, it will determine the degree of control of cardiovascular risk factors in current clinical practice in relation to the European guidelines on cardiovascular prevention. It will also assess physicians' knowledge and attitudes about CVD prevention as well as the barriers impeding effective risk factor management in clinical practice. Methods/Design. Cross-sectional study conducted simultaneously in 12 countries across Europe. The study has two components: firstly at the physician level, assessing eight hundred and nine primary care and specialist physicians with a daily practice in CVD prevention. A physician specific questionnaire captures information regarding physician demographics, practice settings, cardiovascular prevention beliefs and management. Secondly at the patient level, including 7641 patients aged 50 years or older, free of clinical CVD and with at least one classical risk factor, enrolled by the participating physicians. A patient-specific questionnaire captures information from clinical records and patient interview regarding sociodemographic data, CVD risk factors, and current medications. Finally, each patient provides a fasting blood sample, which is sent to a central laboratory for measuring serum lipids, apolipoproteins, hemoglobin-A1c, and inflammatory biomarkers. Discussion. Primary prevention of CVD is an extremely important clinical issue, with preventable circulatory diseases remaining the leading cause of major disease burden. The EURIKA study will provide key information to assess effectiveness of and attitudes toward primary prevention of CVD in Europe. A transnational study creates opportunities for benchmarking good clinical practice across countries and improving outcomes.

AB - Background. The EURIKA study aims to assess the status of primary prevention of cardiovascular disease (CVD) across Europe. Specifically, it will determine the degree of control of cardiovascular risk factors in current clinical practice in relation to the European guidelines on cardiovascular prevention. It will also assess physicians' knowledge and attitudes about CVD prevention as well as the barriers impeding effective risk factor management in clinical practice. Methods/Design. Cross-sectional study conducted simultaneously in 12 countries across Europe. The study has two components: firstly at the physician level, assessing eight hundred and nine primary care and specialist physicians with a daily practice in CVD prevention. A physician specific questionnaire captures information regarding physician demographics, practice settings, cardiovascular prevention beliefs and management. Secondly at the patient level, including 7641 patients aged 50 years or older, free of clinical CVD and with at least one classical risk factor, enrolled by the participating physicians. A patient-specific questionnaire captures information from clinical records and patient interview regarding sociodemographic data, CVD risk factors, and current medications. Finally, each patient provides a fasting blood sample, which is sent to a central laboratory for measuring serum lipids, apolipoproteins, hemoglobin-A1c, and inflammatory biomarkers. Discussion. Primary prevention of CVD is an extremely important clinical issue, with preventable circulatory diseases remaining the leading cause of major disease burden. The EURIKA study will provide key information to assess effectiveness of and attitudes toward primary prevention of CVD in Europe. A transnational study creates opportunities for benchmarking good clinical practice across countries and improving outcomes.

UR - http://www.scopus.com/inward/record.url?scp=77954962237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954962237&partnerID=8YFLogxK

U2 - 10.1186/1471-2458-10-382

DO - 10.1186/1471-2458-10-382

M3 - Article

VL - 10

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

M1 - 382

ER -